The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Financial Services > Investment Firms > BB BIOTECH AG

BB BIOTECH AG
 PROFILE
BB BIOTECH puts forth the cash that may fund the discovery of the next important drug. The venture capital firm invests in biotechnology companies across the globe. BB BIOTECH's portfolio includes large stakes in about a half-dozen companies (including MedImmune and IDEC Pharmaceuticals), as well as smaller shares in a dozen or more others (such as Celera Genomics, Biogen, Third Wave Technologies, and 3-Dimensional Pharmaceuticals). The firm usually makes only limited investments (not taking more than a 10% stake) in non-public companies. BB BIOTECH was also an early investor in Amgen, one of the biggest biotechnology companies in the world.

 COMPETITION
3i Group plc (III)
GlaxoSmithKline plc (GSK)
N M Rothschild & Sons Limited (dossier)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 811.10
1-Yr. Sales Growth: (16.3)%

 KEY PEOPLE
• Anders Hove
    CEO

 CONTACT INFO
Vordergasse 3
8200 Schaffhausen, Switzerland
Phone: 41-52-624-0845
Fax: 41--
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001